Tonder, M. et al. 2014. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica. 53, 10 (Oct. 2014), 1436–1440. DOI:https://doi.org/10.3109/0284186X.2014.920960.